McDermott Will & Emery represented Merck KGaA on the deal. Merck KGaA, Darmstadt, Germany, a leading science and technology company, through its subsidiary Ares Trading S.A.,...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented RAYUS, Inc. in the transaction. Wellspring Capital Management LLC portfolio company RAYUS, Inc. (formerly known as Center for Diagnostic Imaging, Inc.)...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery represented REGENXBIO in the transaction. REGENXBIO closed its $1.8 billion strategic partnership with AbbVie to develop and commercialize RGX-314, a potential one-time...
You must be a Standard 1 Year member to access this content.
